- Home
- HIND vs SEED Comparison
HIND vs SEED Comparison
Compare HIND & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIND | SEED |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | China |
| Employees | 2 | N/A |
| Industry | | Farming/Seeds/Milling |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 12.3M |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | HIND | SEED |
|---|---|---|
| Price | $2.22 | $0.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 62.8K |
| Earning Date | 05-20-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $319,714.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.43 | N/A |
| 52 Week Low | $1.75 | $0.87 |
| 52 Week High | $9.69 | $2.49 |
Technical Indicators
Market Signals| Indicator | HIND | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 43.85 |
| Support Level | $1.99 | $0.97 |
| Resistance Level | $2.35 | $1.06 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 46.03 | 16.62 |
Price Performance
Historical ComparisonAbout HIND Vyome Holdings Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.